Evidence map›Paper›PMID 40052167›Full record

ReviewClinical kidney journal2025

Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA).

Raymond Vanholder, Alicia Bé, Ilaria De Barbieri, Daniel Gallego, Monica Fontana, Marine Faure, Valerie Luyckx, Tom Oostrom, Eveline Scheres, Ole van Vredendaal and 1 more

Abstract readReview
In one paragraph

Review in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Kidney Transplantation in Western Balkans: A Regional Blueprint for Access, Capacity, and Equity.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Raymond VanholderNephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium; EKHA President.ORCID https://orcid.org/0000-0003-2633-1636
Alicia BéAssociate, European Kidney Health Alliance, Brussels, Belgium, Dentons Global Advisors (DGA) Group, Health Practice, Brussels, Belgium.
Ilaria De BarbieriPresident of the European Dialysis and Transplant Nurses Association - Renal Nurses Association (EDTNA-ERCA), Hergiswil, Switzerland; EKHA Board Member.
Daniel GallegoPresident of the European Kidney Patients Federation (EKPF), Vienna, Austria; President of the Spanish Kidney Patients Federation (ALCER), Madrid, Spain; EKHA Board Member.
Monica FontanaExecutive Director, European Renal Association, London, UK; EKHA Board Member.
Marine FaureAssociate Partner, European Kidney Health Alliance, Brussels, Belgium, DGA Group, Health Practice, Brussels, Belgium.
Valerie LuyckxNephrology Department, University Children's Hospital Zürich, Zürich, Switzerland; Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Tom OostromManaging Director Dutch Kidney Foundation, Bussum, The Netherlands; EKHA Treasurer.
Eveline ScheresSenior Strategist, Buitendelijnen, Utrecht, The Netherlands; EKHA General Manager.
Ole van VredendaalEuropean Kidney Health Alliance, Brussels, Belgium; DGA Group, Health Practice, Brussels, Belgium.
Norbert LameireNephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium; EKHA Past President.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is one of the most prevalent and fatal chronic diseases. However, the political attention CKD receives is not proportional to its significant human, economic and ecological burden. One major reason is the lack of awareness among the general population and policymakers. As a result, investment in the therapeutic approaches to CKD have largely remained inadequate, while existing therapies did not change for decades. To respond to the lack of awareness of CKD, several European and international kidney care societies, supported by national and regional organizations, founded the European Kidney Health Alliance (EKHA) in 2007. This Alliance is a Brussels-based advocacy organization representing people with kidney diseases and the kidney care community at the European Union level, and from there, also at the country level. EKHA's aim is to ensure that every candidate for kidney care, irrespective of stage of kidney disease, receives optimal and timely treatment, which is affordable at a societal and individual level. This publication reviews the European political landscape, EKHA's history, points of focus and tools for harnessing available data into advocacy on CKD. Areas discussed include prevention and screening of CKD, its health-economic and environmental impact, and the need to facilitate kidney transplantation and home dialysis. We also examine EKHA's specific approaches to enhance kidney care, its affordability and its sustainability. The EKHA model aims at forestalling the burden of CKD and its underestimated economic and ecologic impact.

Indexed as

advocacyEKHAEuropean Kidney Health AllianceEuropean Unionpolicy

Identifiers

PMID40052167
PMCPMC11883230

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.